Theravance Biopharma Inc (TBPH) — Defensive Interval Ratio
Theravance Biopharma Inc (TBPH) has a Defensive Interval Ratio of 2317 days as of December 2025. Defensive assets of $243.09 Million (cash $-, short-term investments $147.55 Million, receivables $95.54 Million) cover 2317 days of daily cash needs of $104.94K/day. Check TBPH intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Theravance Biopharma Inc Defensive Interval Ratio (2011–2025)
This chart shows how Theravance Biopharma Inc's Defensive Interval Ratio has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 2317 days, meaning defensive assets of $243.09 Million can fund 2317 days of operations without new revenue. Also explore Theravance Biopharma Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Theravance Biopharma Inc (2011–2025)
The table below presents the year-by-year Defensive Interval Ratio for Theravance Biopharma Inc from 2011 to 2025, covering 15 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Theravance Biopharma Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2317 days | $243.09 Million | $104.94K/day | $- | $147.55 Million | ▲ +963 days |
| 2024 | 1354 days | $118.99 Million | $87.90K/day | $- | $50.55 Million | ▲ +169 days |
| 2023 | 1184 days | $80.36 Million | $67.85K/day | $- | $62.88 Million | ▲ +598 days |
| 2022 | 586 days | $46.10 Million | $78.67K/day | $- | $29.31 Million | ▼ -293 days |
| 2021 | 879 days | $141.10 Million | $160.51K/day | $- | $83.51 Million | ▲ +49 days |
| 2020 | 830 days | $281.14 Million | $338.55K/day | $- | $211.47 Million | ▼ -63 days |
| 2019 | 893 days | $273.34 Million | $306.04K/day | $- | $222.77 Million | ▲ +382 days |
| 2018 | 511 days | $137.93 Million | $270.01K/day | $- | $127.25 Million | ▼ -1045 days |
| 2017 | 1556 days | $266.69 Million | $171.38K/day | $- | $259.59 Million | ▲ +330 days |
| 2016 | 1226 days | $165.46 Million | $134.98K/day | $- | $156.39 Million | ▲ +511 days |
| 2015 | 715 days | $96.88 Million | $135.53K/day | $- | $59.73 Million | ▼ -767 days |
| 2014 | 1482 days | $167.53 Million | $113.03K/day | $- | $165.40 Million | ▼ -163 days |
| 2013 | 1645 days | $166.13 Million | $100.97K/day | $- | $165.00 Million | ▲ +1629 days |
| 2012 | 17 days | $1.04 Million | $62.12K/day | $- | $- | ▲ +12 days |
| 2011 | 4 days | $424.00K | $98.30K/day | $- | $- | — |